FDA Inspection
Enestia Belgium NVEnestia Belgium NV – FDA Inspection, Feb 20, 2026
Record Details
This FDA Inspection record concerns Enestia Belgium NV, with an inspection on February 20, 2026, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · f2af55d4-2946-4bf8-9f14-518ac6d5722c
Inspection Facts
- Inspection number
- 1303534
- FDA center
- Biologics
- Project area
- Vaccine, Allergenic, and Live Biotherapeutic Products
FDA Citations
2- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.68(b)Computer control of master formula records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Enestia Belgium NV
4| Date | Classification | Office | Project area |
|---|---|---|---|
| December 13, 2024 | Not classified | Office of Inspections and Investigations | |
| September 19, 2024 | VAI | Office of Inspections and Investigations | Compliance: Medical Devices |
| December 15, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 11, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Enestia Belgium NV
- FDA Inspection 1278760 - 2024-12-13
- FDA Inspection 1250056 - 2024-09-19
- FDA Inspection 1039417 - 2017-12-15
- FDA Inspection 968494 - 2016-03-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.